Literature DB >> 33891661

Up-regulation of cytosolic prostaglandin E synthase in fetal-membrane and amniotic prostaglandin E2 accumulation in labor.

Nanase Takahashi1,2, Toshiaki Okuno1, Hiroki Fujii1, Shintaro Makino3, Masaya Takahashi3, Mai Ohba1, Kazuko Saeki1, Atsuo Itakura2, Satoru Takeda2, Takehiko Yokomizo1.   

Abstract

Prostaglandin E2 (PGE2) is known to have important roles in labor, but the detailed mechanism underlying the spontaneous human labor remains unknown. Here, we examined the involvement of prostaglandin biosynthetic enzymes and transporter in the accumulation of PGE2 in amniotic fluid in human labor. PGE2 and its metabolites were abundant in amniotic fluid in deliveries at term in labor (TLB), but not at term not in labor (TNL). In fetal-membrane Transwell assays, levels of PGE2 production in both maternal and fetal compartments were significantly higher in the TLB group than the TNL group. In fetal-membrane, the mRNA level of PTGES3, which encodes cytosolic prostaglandin E synthase (cPGES), was significantly higher in TLB than in TNL, but the mRNA levels of the other PGE2-synthase genes were not affected by labor. Moreover, the mRNA level of PTGS2, which encodes cyclooxygenase-2 (COX-2) in the amnion was significantly higher in TLB than in TNL. Western blot analyses revealed that the levels of COX-1 and COX-2 were comparable between the two groups, however, the level of cPGES was relatively higher in TLB than in TNL. COXs, cPGES, and prostaglandin transporter (SLCO2A1) proteins were all expressed in both chorionic trophoblasts and amniotic epithelium. These findings suggest that COXs, cPGES and SLCO2A1 contribute to PGE2 production from fetal-membrane in labor.

Entities:  

Year:  2021        PMID: 33891661     DOI: 10.1371/journal.pone.0250638

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  Prostaglandins in biofluids in pregnancy and labour: A systematic review.

Authors:  Eilidh M Wood; Kylie K Hornaday; Donna M Slater
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

2.  Fetal Membranes Contribute to Drug Transport across the Feto-Maternal Interface Utilizing the Breast Cancer Resistance Protein (BCRP).

Authors:  Ananthkumar Kammala; Meagan Benson; Esha Ganguly; Enkhtuya Radnaa; Talar Kechichian; Lauren Richardson; Ramkumar Menon
Journal:  Life (Basel)       Date:  2022-01-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.